People: Two Alzheimer's Research Teams Net MetLife Medical Awards

On February 15, the New York-based Metropolitan Life (MetLife) Foundation recognized two teams of biomedical scientists for the significance of their research and the collaborative nature of their work. The cash portion of the prize, known as the Awards for Medical Research, totaled $500,000. It was shared by the team of Robert W. Mahley, director of the Gladstone Institute of Cardiovascular Disease and a professor of pathology and medicine at the University of California, San Francisco, and Ka

Written byKaren Young Kreeger
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

On February 15, the New York-based Metropolitan Life (MetLife) Foundation recognized two teams of biomedical scientists for the significance of their research and the collaborative nature of their work. The cash portion of the prize, known as the Awards for Medical Research, totaled $500,000. It was shared by the team of Robert W. Mahley, director of the Gladstone Institute of Cardiovascular Disease and a professor of pathology and medicine at the University of California, San Francisco, and Karl Weisgraber, associate director at Gladstone and a UC-San Francisco professor of pathology; and the team of Alison Goate, an associate professor of genetics in psychiatry at Washington University, and John Hardy, director of the Alzheimer's Research Laboratory and Pfeiffer Endowed Professor in the department of psychiatry and behavioral medicine at the University of South Florida.

According to MetLife officials, this is the first time that four people have shared the award and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies